Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study.
Hannawi S, Zhang RR, Abuquta A, Safeldin L, Hassan A, Alamadi A, Hossain T, Mostafa M, Ghoneim Y, Solo J, Zheng HX, Wu DF, Yu DD, Yuan JC, Zhao D, Lin R, Ying B, Qin CF.
Hannawi S, et al. Among authors: ghoneim y.
Clin Transl Med. 2023 Aug;13(8):e1387. doi: 10.1002/ctm2.1387.
Clin Transl Med. 2023.
PMID: 37612802
Free PMC article.
Clinical Trial.
No abstract available.